Infectious colitis future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Category |
||
Line 7: | Line 7: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WS}}{{WH}} | {{WS}}{{WH}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] |
Revision as of 16:26, 21 September 2017
Infectious colitis Microchapters |
Infectious colitis future or investigational therapies On the Web |
American Roentgen Ray Society Images of Infectious colitis future or investigational therapies |
FDA on Infectious colitis future or investigational therapies |
CDC on Infectious colitis future or investigational therapies |
Infectious colitis future or investigational therapies in the news |
Blogs on Infectious colitis future or investigational therapies |
Risk calculators and risk factors for Infectious colitis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qasim Salau, M.B.B.S., FMCPaed [2]